AI-designed drug shows '3 years younger' across six aging clocks
Insilico Medicine gave patients its AI-designed pulmonary fibrosis drug rentosertib for 12 weeks, and their biological age dropped on all six aging clocks tested — by more than three years in some cases. The drug was made by AI, and its effects were measured by AI. So how much should we trust these numbers?


